Novartis has a history of charging high prices for drugs in Colombia “This data supports the idea that Gleevec has not been the only drug for which Novartis has, historically, overcharged,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst for Health GAP, a group that advocates for wider access to medicines. “And it shows the unilateral power of companies […]